Funding Wrap of the Week | American Startups Funding Roundup | June 9 – June 14

There are a lot of American startups funding deals that are creating buzz around the startup ecosystem. These are the growth-stage and early-stage deals of this week. Let’s talk about the Top 10 Funding deals. 

The Top 10 American Startups Funding Deals

Flo

FLO, a leading North American electric vehicle (EV) charging network operator and smart charging solutions provider, secures $136million in funding, principally from a Series E equity financing, led by Export Development Canada (EDC), to support the company’s continued growth in both the U.S. and Canada and accelerate the deployment of its reliable charging network.

FLO is a leading North American electric vehicle (EV) charging network operator and a smart charging solutions provider. They help to overcome climate change and accelerate EV adoption through a vertically integrated business model and by delivering EV drivers the best charging experience from curbside to countryside.

Kardium Inc

Kardium Inc., the developer of the Globe® Mapping and Ablation System for the treatment of atrial fibrillation, secures $104million in new funding. The lead investor in the round was Fidelity Management & Research Company, with additional participation from new investment Durable Capital Partners LP and funds and accounts handled by T. Rowe Price Associates, Inc. and T. Rowe Price Investment Management, Inc.

The fast-growing medical solutions business Kardium Inc. has created a cutting-edge technology to treat atrial fibrillation (AF), a condition that affects over 59 million individuals globally.

Alzheon

Alzheon, a clinical-stage biopharmaceutical company, secures $100million in series E round funding. The round was led by Alerce Medical Technology Partners. The business, which in 2022 successfully collected $50 million in a Series D financing round, plans to use the money to grow both its R&D sector and its operations.

Alzheon, Inc. is dedicated to creating cutting-edge medications by tackling the underlying pathology of debilitating neurodegenerative illnesses head-on. Their top option for treating Alzheimer’s disease, ALZ-801, is an oral small molecule prodrug of tramiprosate that completely prevents the brain from producing harmful soluble amyloid oligomers.

Mad Mobile

Mad Mobile, a company which specializes in restaurant and retail SaaS and payment solutions, secures $50million in funding. Morgan Stanley Expansion Capital and Bridge Bank were among the backers.

Mad Mobile, they use dependable and creative technology to make hospitality more effective and easy to use. They think that all restaurant, retail, and hospitality transactions will eventually be conducted via mobile devices.

Canary Technologies

Canary Technologies, the global leader in hotel guest management technology, secures $50million in series C round funding. The round was led by global software investor Insight Partners, who also led the company’s Series B, with participation from existing investors F-Prime Capital, Thayer Ventures, Y-Combinator, and Commerce Ventures.

‍Canary Technologies is modernizing the hotel tech stack with its award-winning end-to-end Guest Management Platform. Digitizing everything from post-booking through checkout, Canary is trusted by more than 20,000 hoteliers in 80+ countries, including leading global brands, such as Marriott International, Four Seasons, Choice Hotels, Wyndham Hotels & Resorts, Rosewood and Intercontinental Hotel Group. 

Avava

Avava, a medical aesthetics platform company, secures $35million in funding. The round consisted of $25M in proceeds from new and existing investors including its strategic partner, Jeisys Medical, Inc, and $10M in growth capital from Catalio Capital Management.

AVAVA™ developed a new class of FDA-cleared, non-invasive aesthetic medical devices with patented precision technology to provide best in class patient and provider experience for all skin tones.

Relay

Relay, the cloud-based communications platform designed to improve productivity and safety for frontline teams, secures $35 million in series B round funding. This round was led by G2 Venture Partners, with continued support from their existing investors including Wind River Ventures and Sovereign’s Capital.

Relay is a cloud-based technology platform that enhances worker safety, productivity, and communication for frontline teams. With the use of cutting-edge technologies that enable actionable real-time data necessary to monitor performance and enhance operations, it assists frontline teams in digitally transforming their business processes. 

Anterior

Anterior, the AI company built by clinicians to transform healthcare administration, secures $20 million in series A round funding. The funding round was led by New Enterprise Associates (NEA), with participation from Sequoia Capital, Blue Lion Global, and Neo. Previously named Co:Helm, the company recently rebranded to Anterior.

Anterior, formerly named Co:Helm, is on a mission to unlock doctors and nurses from the administrative burden they experience. Built by clinicians, for clinicians, it is creating the foundation for the future of healthcare to reduce the near trillion-dollar administrative burden in the U.S.

Alexi

Alexi, a Legaltech company and leader in generative AI for legal research and litigation tasks, secures $11million in series A round funding. Drive Capital is leading the round, and Draper Associates and other current investors are participating. 

Alexi’s unique AI-powered platform, founded by Mark Doble and Sam Bhasin, gives litigators essential legal abilities. It is a time-saving tool that increases productivity for law firms by streamlining the legal research process and helping with standard litigation activities.

Auxilius

Auxilius, a provider of clinical trial financial management (CTFM) software, secures $10million in funding. SignalFire was leading the round. The money will be used by the business to increase operations and development initiatives.

Leading cloud-based Clinical Trial Financial Management (CTFM) software supplier is Auxilius. Life Sciences organisations can benefit from advanced investigator spend analytics, faster clinical trial planning, and accurate and timely financial closing thanks to the Auxilius platform.

Frequently asked questions (FAQs)